Anxiety and Related Sleep Disorders - Gambia

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$4.28m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.38%, resulting in a market volume of US$4.36m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$33.54 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Gambia is experiencing significant growth and development.

Customer preferences: Customers in Gambia are increasingly seeking solutions for anxiety and related sleep disorders. This can be attributed to the growing awareness about mental health and the importance of quality sleep. Customers are looking for effective and safe treatments that can help them manage their anxiety and improve their sleep patterns. They are also interested in natural and holistic remedies, as well as non-medication options such as therapy and relaxation techniques.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Gambia is the increasing demand for pharmaceutical products. As the healthcare infrastructure in the country continues to improve, more people have access to medications for anxiety and sleep disorders. This trend is also driven by the rising urbanization and changing lifestyles, which often lead to higher stress levels and sleep disturbances. Additionally, the availability of a wider range of medications and treatment options has contributed to the growth of the market.

Local special circumstances: Gambia, being a developing country, faces unique challenges in addressing the needs of its population when it comes to mental health. Limited access to healthcare facilities and trained professionals, as well as cultural stigmas surrounding mental health, can hinder the effective management of anxiety and sleep disorders. However, the government and various non-profit organizations are working towards increasing awareness, improving access to healthcare services, and reducing the stigma associated with mental health.

Underlying macroeconomic factors: The growth of the Anxiety and Related Sleep Disorders market in Gambia can be attributed to several underlying macroeconomic factors. The country's economy has been steadily growing, leading to an increase in disposable income among the population. As a result, more people are able to afford healthcare services and medications for their anxiety and sleep disorders. Additionally, the government's focus on improving the healthcare sector and expanding access to healthcare services has also contributed to the growth of the market. Furthermore, the increasing prevalence of anxiety and related sleep disorders globally has created a demand for effective treatments, which has translated into the growth of the market in Gambia as well.In conclusion, the Anxiety and Related Sleep Disorders market in Gambia is experiencing significant growth due to increasing customer preferences for effective treatments, the availability of a wider range of medications, and the underlying macroeconomic factors such as economic growth and government initiatives to improve healthcare services. However, challenges such as limited access to healthcare facilities and cultural stigmas surrounding mental health still need to be addressed to ensure the effective management of anxiety and sleep disorders in the country.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.